Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

GS-840 progresses through clinical trials

Jan. 21, 1997

Allelix refocuses drug development program

Jan. 21, 1997

Viracept licensed to Roche

Jan. 21, 1997

Triangle reports preliminary clinical results with anti-HIV compound

Jan. 20, 1997

NCI study indicates potential teratogenicity of AZT

Jan. 20, 1997

Hybridon to begin French clinical trials on anti-CMV antisense compound

Jan. 17, 1997

New treatment option for HIV-infected children

Jan. 17, 1997

Isis and UCSF awarded grant for combinatorial drug discovery

Jan. 17, 1997

Paracelsian signs CRADA with NCI

Jan. 16, 1997

Combination protease inhibitor trial with 141W94/VX-478

Jan. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...